• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

戒烟计划后高危人群中可溶性 CD44 水平降低。

Decreased Levels of Soluble CD44 in a High-Risk Population following a Smoking Cessation Program.

机构信息

Department of Otolaryngology-Head and Neck Surgery, University of Miami Leonard Miller School of Medicine, Miami, FL 33136, USA.

Herbert Wertheim College of Medicine, Florida International University, Miami, FL 33199, USA.

出版信息

Int J Environ Res Public Health. 2021 Dec 14;18(24):13174. doi: 10.3390/ijerph182413174.

DOI:10.3390/ijerph182413174
PMID:34948786
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8700947/
Abstract

Tobacco is a risk factor of head and neck cancer (HNC) and smoking cessation alone may reduce HNC risk by 70%. Soluble CD44 (solCD44), a cell surface receptor linked to cell proliferation and migration, and total protein (TP) levels can detect early HNC. This study aims to determine whether salivary solCD44 and TP levels in oral rinses change following a smoking cessation program. 150 smokers provided oral rinse samples at baseline and at a 12-month follow-up after participation in a smoking cessation program. Assays to measure levels of solCD44, TP, and cotinine, a metabolite used as a biomarker of tobacco exposure, were completed. A paired-samples t-test was used to determine whether there was a statistically significant ( < 0.05) mean difference in biomarker levels before and after the program. Baseline and at 12-month follow-up data were available for 88 subjects, 21 of whom quit smoking entirely. Mean levels of solCD44 significantly decreased by 0.412 ng/mL from baseline to the 12-month follow-up, = 0.010. There was no significant difference in mean TP levels, = 0.975. Mean cotinine levels decreased significantly by 74.7 ng/mL, = 0.035. This is the first work demonstrating an association between smoking cessation and decreased solCD44 levels in oral rinses. Decreased expression of the tumorigenic CD44 may be one mechanism by which smoking cessation lowers cancer risk.

摘要

烟草是头颈部癌症(HNC)的一个风险因素,单独戒烟可使 HNC 风险降低 70%。可溶性 CD44(solCD44)是一种与细胞增殖和迁移相关的细胞表面受体,总蛋白(TP)水平可检测早期 HNC。本研究旨在确定戒烟计划后漱口液中的唾液可溶性 CD44 和 TP 水平是否发生变化。150 名吸烟者在参与戒烟计划前和 12 个月随访时提供了漱口样本。完成了测量 solCD44、TP 和可替宁(一种用于检测烟草暴露的生物标志物)水平的测定。使用配对样本 t 检验确定在计划前后生物标志物水平是否存在统计学上显著差异(<0.05)。88 名受试者中有 21 名完全戒烟,他们的基线和 12 个月随访数据可用。与基线相比,12 个月随访时 solCD44 的平均水平显著下降了 0.412ng/mL,=0.010。TP 平均水平无显著差异,=0.975。可替宁平均水平显著下降了 74.7ng/mL,=0.035。这是首次证明戒烟与漱口液中 solCD44 水平降低之间存在关联的工作。肿瘤发生 CD44 表达的减少可能是戒烟降低癌症风险的一种机制。

相似文献

1
Decreased Levels of Soluble CD44 in a High-Risk Population following a Smoking Cessation Program.戒烟计划后高危人群中可溶性 CD44 水平降低。
Int J Environ Res Public Health. 2021 Dec 14;18(24):13174. doi: 10.3390/ijerph182413174.
2
Soluble CD44 in oral rinses for the early detection of cancer: a prospective cohort study in high-risk individuals.口腔冲洗液中的可溶性 CD44 用于癌症的早期检测:高危人群的前瞻性队列研究。
BMC Oral Health. 2024 Jul 19;24(1):820. doi: 10.1186/s12903-024-04463-8.
3
CD44 and associated markers in oral rinses and tissues from oral and oropharyngeal cancer patients.口腔和口咽癌患者漱口液和组织中的 CD44 及相关标志物。
Oral Oncol. 2020 Jul;106:104720. doi: 10.1016/j.oraloncology.2020.104720. Epub 2020 Apr 20.
4
Soluble CD44 is a potential marker for the early detection of head and neck cancer.可溶性CD44是早期检测头颈癌的一个潜在标志物。
Cancer Epidemiol Biomarkers Prev. 2007 Jul;16(7):1348-55. doi: 10.1158/1055-9965.EPI-06-0011.
5
Salivary protein and solCD44 levels as a potential screening tool for early detection of head and neck squamous cell carcinoma.唾液蛋白和可溶性 CD44 水平作为头颈部鳞状细胞癌早期检测的潜在筛查工具。
Head Neck. 2012 May;34(5):687-95. doi: 10.1002/hed.21810. Epub 2011 Jul 11.
6
Salivary markers and risk factor data: a multivariate modeling approach for head and neck squamous cell carcinoma detection.唾液标志物和危险因素数据:用于头颈部鳞状细胞癌检测的多变量建模方法。
Cancer Biomark. 2011;10(5):241-9. doi: 10.3233/cbm-2012-0252.
7
Salivary soluble CD44: a potential molecular marker for head and neck cancer.唾液可溶性CD44:头颈部癌的潜在分子标志物。
Cancer Epidemiol Biomarkers Prev. 2005 Mar;14(3):735-9. doi: 10.1158/1055-9965.EPI-04-0546.
8
Social environment, secondary smoking exposure, and smoking cessation among head and neck cancer patients.社会环境、二手烟暴露与头颈部癌症患者的戒烟行为。
Cancer. 2013 Aug 1;119(15):2701-9. doi: 10.1002/cncr.28088. Epub 2013 Jun 13.
9
Green Salad Intake Is Associated with Improved Oral Cancer Survival and Lower Soluble CD44 Levels.食用绿色沙拉与改善口腔癌患者生存状况和降低可溶性 CD44 水平有关。
Nutrients. 2021 Jan 26;13(2):372. doi: 10.3390/nu13020372.
10
Parents' Self-efficacy for Tobacco Exposure Protection and Smoking Abstinence Mediate Treatment Effects on Child Cotinine at 12-Month Follow-up: Mediation Results from the Kids Safe and Smokefree Trial.家长对烟草暴露防护和戒烟的自我效能在 12 个月随访时中介了治疗对儿童可替宁的影响:来自 Kids Safe and Smokefree 试验的中介结果。
Nicotine Tob Res. 2020 Oct 29;22(11):1981-1988. doi: 10.1093/ntr/ntz175.

引用本文的文献

1
Validation of salivary proteomic biomarkers for early detection of oral cancer in the Egyptian population.唾液蛋白质组学生物标志物用于埃及人群口腔癌早期检测的验证
Future Sci OA. 2025 Dec;11(1):2432222. doi: 10.1080/20565623.2024.2432222. Epub 2024 Dec 6.
2
Soluble CD44 in oral rinses for the early detection of cancer: a prospective cohort study in high-risk individuals.口腔冲洗液中的可溶性 CD44 用于癌症的早期检测:高危人群的前瞻性队列研究。
BMC Oral Health. 2024 Jul 19;24(1):820. doi: 10.1186/s12903-024-04463-8.

本文引用的文献

1
Green Salad Intake Is Associated with Improved Oral Cancer Survival and Lower Soluble CD44 Levels.食用绿色沙拉与改善口腔癌患者生存状况和降低可溶性 CD44 水平有关。
Nutrients. 2021 Jan 26;13(2):372. doi: 10.3390/nu13020372.
2
Recent Advances and Future Directions in Clinical Management of Head and Neck Squamous Cell Carcinoma.头颈部鳞状细胞癌临床管理的最新进展与未来方向
Cancers (Basel). 2021 Jan 18;13(2):338. doi: 10.3390/cancers13020338.
3
CD44 as a tumor biomarker and therapeutic target.CD44作为一种肿瘤生物标志物和治疗靶点。
Exp Hematol Oncol. 2020 Dec 10;9(1):36. doi: 10.1186/s40164-020-00192-0.
4
Head and neck squamous cell carcinoma.头颈部鳞状细胞癌
Nat Rev Dis Primers. 2020 Nov 26;6(1):92. doi: 10.1038/s41572-020-00224-3.
5
CD44 and associated markers in oral rinses and tissues from oral and oropharyngeal cancer patients.口腔和口咽癌患者漱口液和组织中的 CD44 及相关标志物。
Oral Oncol. 2020 Jul;106:104720. doi: 10.1016/j.oraloncology.2020.104720. Epub 2020 Apr 20.
6
Assessment of cotinine in urine and saliva of smokers, passive smokers, and nonsmokers: Method validation using liquid chromatography and mass spectrometry.吸烟者、被动吸烟者和非吸烟者尿液及唾液中可替宁的评估:使用液相色谱和质谱法进行方法验证
Indian J Psychiatry. 2019 May-Jun;61(3):270-276. doi: 10.4103/psychiatry.IndianJPsychiatry_61_18.
7
The biology and role of CD44 in cancer progression: therapeutic implications.CD44 在癌症进展中的生物学和作用:治疗意义。
J Hematol Oncol. 2018 May 10;11(1):64. doi: 10.1186/s13045-018-0605-5.
8
Effect of Smoking Cessation and Reduction on the Risk of Cancer in Korean Men: A Population Based Study.韩国男性戒烟和减少吸烟量对癌症风险的影响:一项基于人群的研究。
Cancer Res Treat. 2018 Oct;50(4):1114-1120. doi: 10.4143/crt.2017.326. Epub 2017 Nov 24.
9
Tobacco and alcohol cessation or reduction interventions in people with oral dysplasia and head and neck cancer: systematic review protocol.口腔发育异常和头颈部癌症患者的烟草和酒精戒断或减少干预措施:系统评价方案。
Syst Rev. 2017 Aug 10;6(1):161. doi: 10.1186/s13643-017-0555-y.
10
Periodontal Disease, Tooth Loss, and Cancer Risk.牙周病、牙齿脱落与癌症风险。
Epidemiol Rev. 2017 Jan 1;39(1):49-58. doi: 10.1093/epirev/mxx006.